← FDA Drug Approvals (Drugs@FDA)
LEVETIRACETAM IN SODIUM CHLORIDE
NDA · New Drug Application · Sponsor: HQ SPCLT PHARMA · Approved 2011-11-09
Drug application
- FDA Application #
NDA202543- Application type
- New Drug Application
- Brand name
- LEVETIRACETAM IN SODIUM CHLORIDE
- Generic name
- LEVETIRACETAM
- Active ingredients
- LEVETIRACETAM
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- HQ SPCLT PHARMA
- Manufacturer
- WG Critical Care, LLC
- First approval
- 2011-11-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown